Referências
Principais artigos
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.Texto completo Resumo
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Texto completo Resumo
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.Texto completo Resumo
Artigos de referência
1. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.Texto completo Resumo
2. Hamburger JI, Taylor CI. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med. 1979 Sep;91(3):406-9. Resumo
3. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51.Texto completo Resumo
4. Muller AF, Berghout A, Wiersing WM, et al. Thyroid function disorders - guidelines of the Netherlands Association of Internal Medicine. Neth J Med. 2008 Mar;66(3):134-42.Texto completo Resumo
5. Abraham-Nordling M, Törring O, Lantz M, et al. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. Eur J Endocrinol. 2008;158(6):823-7.Texto completo Resumo
6. Cooper DS. Hyperthyroidism. Lancet. 2003 Aug 9;362(9382):459-68. Resumo
7. Corvilain B. The natural history of thyroid autonomy and hot nodules. Ann Endocrinol (Paris). 2003;64:17-22. Resumo
8. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug 27;388(10047):906-18.Texto completo Resumo
9. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.Texto completo Resumo
10. Brtko J, Bobalova J, Podoba J, et al. Thyroid hormone receptors and type I iodothyronine 5'-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Exp Clin Endocrinol Diabetes. 2002 Jun;110(4):166-70. Resumo
11. Krohn K, Führer D, Holzapfel HP, et al. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab. 1998 Jan;83(1):130-4. Resumo
12. Führer D. Constitutive TSH receptor activation as a hallmark of thyroid autonomy. Endocrine. 2020 May;68(2):274-8.Texto completo Resumo
13. Derwahl M. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas - a note of caution. J Clin Endocrinol Metab. 1996 Aug;81(8):2783-5. Resumo
14. Krohn K, Fuhrer D, Bayer Y, et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev. 2005 Jun;26(4):504-24. Resumo
15. Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018 Mar;7(2):55-66.Texto completo Resumo
16. Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev. 1999 Oct;79(4):1373-430. Resumo
17. Poertl S, Kirner J, Saller B, et al. T3-release from autonomously functioning thyroid nodules in vitro. Exp Clin Endocrinol Diabetes. 1998;106(6):489-93. Resumo
18. Polak M. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene. Arch Med Res. 1999 Nov-Dec;30(6):510-3. Resumo
19. Derwahl M, Hamacher C, Russo D, et al. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab. 1996 May;81(5):1898-904. Resumo
20. Tonacchera M, Vitti P, De Servi M, et al. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis. J Endocrinol Invest. 2003;26(2 suppl):2-6. Resumo
21. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015 Apr;3(4):286-95. Resumo
22. Fiore E, Tonacchera M, Vitti P. Influence of iodization programmes on the epidemiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):577-88. Resumo
23. Maniakas A, Davies L, Zafereo ME. Thyroid disease around the world. Otolaryngol Clin North Am. 2018 Jun;51(3):631-42. Resumo
24. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Texto completo Resumo
25. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.Texto completo Resumo
26. Scappaticcio L, Longo M, Maiorino MI, et al. Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis. Thyroid. 2021 Jun;31(6):884-94.Texto completo Resumo
27. Scappaticcio L, Maiorino MI, Maio A, et al. Neutropenia in patients with hyperthyroidism: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2021 Mar;94(3):473-83. Resumo
28. Thiruvengadam S, Luthra P. Thyroid disorders in elderly: a comprehensive review. Dis Mon. 2021 Nov;67(11):101223. Resumo
29. Kakuno Y, Amino N, Kanoh M, et al. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57(12):1017-22.Texto completo Resumo
30. Gorenek B, Boriani G, Dan GA, et al. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace. 2018 Jun 1;20(6):895-6.Texto completo Resumo
31. Intenzo CM, dePapp AE, Jabbour S, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003 Jul-Aug;23(4):857-69. Resumo
32. Baldini M, Orsatti A, Cantalamessa L. A singular case of Graves' disease in congenital thyroid hemiagenesis. Horm Res. 2005;63(3):107-10. Resumo
33. US Preventive Services Task Force. Thyroid dysfunction: screening. Jul 2015 [internet publication].Texto completo
34. Tankeu AT, Azabji-Kenfack M, Nganou CN, et al. Effect of propranolol on heart rate variability in hyperthyroidism. BMC Res Notes. 2018 Feb 22;11(1):151.Texto completo Resumo
35. Ross DS. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011 Feb 10;364(6):542-50. Resumo
36. Tarantini B, Ciuoli C, DiCairano G, et al. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. J Endocrinol Invest. 2006 Jul-Aug;29(7):594-8. Resumo
37. Nygaard B, Hegedus L, Nielsen KG, et al. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999 Feb;50(2):197-202. Resumo
38. Erdogan MF, Kucuk NO, Anil C, et al. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas. Nucl Med Commun. 2004 Nov;25(11):1083-7. Resumo
39. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65.Texto completo Resumo
40. Morales DR, Fonkwen L, Nordeng HME. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations. Br J Clin Pharmacol. 2021 Oct;87(10):3890-900.Texto completo Resumo
41. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar;27(3):315-89.Texto completo Resumo
42. Biondi B, Cooper DS. Subclinical Hyperthyroidism. N Engl J Med. 2018 Jun 21;378(25):2411-9. Resumo
43. Evron JM, Papaleontiou M. Decision making in subclinical thyroid disease. Med Clin North Am. 2021 Nov;105(6):1033-45. Resumo
44. Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ. 2006 Jun 10;332(7554):1369-73. Resumo
45. Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005 Aug 15;72(4):623-30. Resumo
46. Cooper DS. Antithyroid drugs. N Engl J Med. 2005 Mar 3;352(9):905-17. Resumo
47. Karras S, Tzotzas T, Krassas GE. Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives. Hormones (Athens). 2009 Oct-Dec;8(4):254-7. Resumo
48. Stan MN, Papaleontiou M, Schmitz JJ, et al. Nonsurgical management of thyroid nodules: the role of ablative therapies. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1417-30.Texto completo Resumo
49. Barile A, Quarchioni S, Bruno F, et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018 Apr;7(2):132-46.Texto completo Resumo
50. Muhammad H, Tehreem A, Russell JO, et al. Radiofrequency ablation and autonomous functioning thyroid nodules: review of the current literature. Laryngoscope. 2022 Apr;132(4):906-14. Resumo
51. Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015 May;100(5):1903-11. Resumo
52. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71. Resumo
53. Ceccarelli C, Bencivelli W, Vitti P, et al. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf). 2005 Mar;62(3):331-5. Resumo
54. Delitala AP, Scuteri A, Doria C. Thyroid hormone diseases and osteoporosis. J Clin Med. 2020 Apr 6;9(4):1034.Texto completo Resumo
55. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012 Mar 24;379(9821):1155-66. Resumo
56. Tzavara I, Tzanela M, Vlassopoulou B, et al. Long term thyroid function after (131)I treatment for toxic adenoma. Hormones (Athens). 2002 Apr-Jun;1(2):99-103. Resumo
57. Verloop H, Louwerens M, Schoones JW, et al. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012 Jul;97(7):2243-55.Texto completo Resumo
58. American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC, Freitas J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011 Apr;21(4):335-46. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal